P.hd in Reproductive Health Research:3,4,6-triaryl-2-pyranones and 2,3,4-triarylbenzopyran derivatives as a new class of therapeutic agent for breast cancer.

CDRI was inaugurated on 17th Feb 1951. It is one of the most important research institute in the field of biomedical research. Scientists here used latest scientific technology and techniques are used to develop drugs, vaccination and diagnostics.
Cancer belongs to the class of disease characterized by out-of-control cell growth. Cancer is harmful when cells divide uncontrollably to form masses of tissues. The term "breast cancer" refers to a malignant tumor that has developed from cells in the breast. It is a very common disease found in women.
Scientists have developed 3,4,6-triaryl-2-pyranones and 2,3,4-triarylbenzopyran derivatives as a new class of therapeutic agent for breast cancer.